FDA grants orphan designation to DHODH inhibitor for AMLAugust 21, 2018Leukemia, Myelodysplasia, Transplantation
FDA puts partial hold on trial of vascular agent for AML, MDSAugust 20, 2018Leukemia, Myelodysplasia, Transplantation
FDA requires companion diagnostics for checkpoint inhibitors in urothelial cancerAugust 20, 2018Genitourinary Cancer
Leptin expression may help differentiate renal lesionsAugust 17, 2018Renal Cell CarcinomaGenitourinary Cancer
Feds aim to streamline gene therapy oversightAugust 16, 2018Practice ManagementImmuno-oncologyGene Therapy
Having prescription drug coverage is associated with improved myeloma outcomesAugust 16, 2018Practice ManagementLymphoma & Plasma Cell Disorders
